Switch to:
Also traded in: Australia, Germany

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 4/10

vs
industry
vs
history
Cash to Debt 0.99
HTWR's Cash to Debt is ranked lower than
64% of the 325 Companies
in the Global Medical Devices industry.

( Industry Median: 2.28 vs. HTWR: 0.99 )
Ranked among companies with meaningful Cash to Debt only.
HTWR' s Cash to Debt Range Over the Past 10 Years
Min: 0.99  Med: 2.21 Max: No Debt
Current: 0.99
Equity to Asset 0.41
HTWR's Equity to Asset is ranked lower than
79% of the 300 Companies
in the Global Medical Devices industry.

( Industry Median: 0.64 vs. HTWR: 0.41 )
Ranked among companies with meaningful Equity to Asset only.
HTWR' s Equity to Asset Range Over the Past 10 Years
Min: 0.33  Med: 0.57 Max: 0.96
Current: 0.41
0.33
0.96
F-Score: 1
Z-Score: 0.63
M-Score: -3.23
WACC vs ROIC
6.06%
-30.72%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 4/10

vs
industry
vs
history
Operating margin (%) -17.24
HTWR's Operating margin (%) is ranked lower than
64% of the 307 Companies
in the Global Medical Devices industry.

( Industry Median: 2.61 vs. HTWR: -17.24 )
Ranked among companies with meaningful Operating margin (%) only.
HTWR' s Operating margin (%) Range Over the Past 10 Years
Min: -8846.69  Med: -52.07 Max: -0.04
Current: -17.24
-8846.69
-0.04
Net-margin (%) -28.91
HTWR's Net-margin (%) is ranked lower than
67% of the 307 Companies
in the Global Medical Devices industry.

( Industry Median: 0.86 vs. HTWR: -28.91 )
Ranked among companies with meaningful Net-margin (%) only.
HTWR' s Net-margin (%) Range Over the Past 10 Years
Min: -7157.83  Med: -59.91 Max: -6.96
Current: -28.91
-7157.83
-6.96
ROE (%) -39.59
HTWR's ROE (%) is ranked lower than
75% of the 299 Companies
in the Global Medical Devices industry.

( Industry Median: 1.05 vs. HTWR: -39.59 )
Ranked among companies with meaningful ROE (%) only.
HTWR' s ROE (%) Range Over the Past 10 Years
Min: -99.79  Med: -43.63 Max: -9.51
Current: -39.59
-99.79
-9.51
ROA (%) -16.59
HTWR's ROA (%) is ranked lower than
66% of the 325 Companies
in the Global Medical Devices industry.

( Industry Median: -0.34 vs. HTWR: -16.59 )
Ranked among companies with meaningful ROA (%) only.
HTWR' s ROA (%) Range Over the Past 10 Years
Min: -86.09  Med: -30.14 Max: -4.54
Current: -16.59
-86.09
-4.54
ROC (Joel Greenblatt) (%) -116.74
HTWR's ROC (Joel Greenblatt) (%) is ranked lower than
70% of the 321 Companies
in the Global Medical Devices industry.

( Industry Median: 4.07 vs. HTWR: -116.74 )
Ranked among companies with meaningful ROC (Joel Greenblatt) (%) only.
HTWR' s ROC (Joel Greenblatt) (%) Range Over the Past 10 Years
Min: -771.28  Med: -127.19 Max: -10.07
Current: -116.74
-771.28
-10.07
Revenue Growth (3Y)(%) 27.20
HTWR's Revenue Growth (3Y)(%) is ranked higher than
94% of the 236 Companies
in the Global Medical Devices industry.

( Industry Median: 3.60 vs. HTWR: 27.20 )
Ranked among companies with meaningful Revenue Growth (3Y)(%) only.
HTWR' s Revenue Growth (3Y)(%) Range Over the Past 10 Years
Min: 0  Med: 40.30 Max: 420.7
Current: 27.2
0
420.7
EBITDA Growth (3Y)(%) -17.40
HTWR's EBITDA Growth (3Y)(%) is ranked lower than
80% of the 201 Companies
in the Global Medical Devices industry.

( Industry Median: 1.90 vs. HTWR: -17.40 )
Ranked among companies with meaningful EBITDA Growth (3Y)(%) only.
HTWR' s EBITDA Growth (3Y)(%) Range Over the Past 10 Years
Min: -17.4  Med: -7.85 Max: 36.5
Current: -17.4
-17.4
36.5
EPS Growth (3Y)(%) -11.90
HTWR's EPS Growth (3Y)(%) is ranked lower than
68% of the 203 Companies
in the Global Medical Devices industry.

( Industry Median: 2.60 vs. HTWR: -11.90 )
Ranked among companies with meaningful EPS Growth (3Y)(%) only.
HTWR' s EPS Growth (3Y)(%) Range Over the Past 10 Years
Min: -33.9  Med: -11.90 Max: 41.9
Current: -11.9
-33.9
41.9
» HTWR's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow
Oprt. Cash Flow & Net Income

» Details

Guru Trades

Q2 2015

HTWR Guru Trades in Q2 2015

Jim Simons 39,300 sh (+120.79%)
Manning & Napier Advisors, Inc 653,020 sh (-1.18%)
» More
Q3 2015

HTWR Guru Trades in Q3 2015

Steven Cohen 333,800 sh (New)
Manning & Napier Advisors, Inc Sold Out
Jim Simons Sold Out
» More
Q4 2015

HTWR Guru Trades in Q4 2015

Jim Simons 50,000 sh (New)
Steven Cohen Sold Out
» More
Q1 2016

HTWR Guru Trades in Q1 2016

Michael Price 30,000 sh (New)
Jim Simons 192,448 sh (+284.90%)
» More
» Details

Insider Trades

Latest Guru Trades with HTWR

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Business Description

Industry: Medical Devices » Medical Devices
Compare:OTCPK:JIDG, NAS:CSII, NAS:KTWO, NAS:ARAY, NAS:VASC, OTCPK:PMTHF, OTCPK:MCRPF, NYSE:CRY, NYSE:IVC, OTCPK:MZRTF, NAS:XENT, NAS:EXAC, OTCPK:NMRD, NAS:GNMK, OTCPK:CSRMF, OTCPK:IPDQF, NAS:SPNC, NAS:OFIX, NAS:ELOS, NAS:IRMD » details
Traded in other countries:HIN.Australia, HIY1.Germany,
Heartware International Inc is a medical device company. It develops and manufactures small implantable heart pumps, or ventricular assist devices, for the treatment of heart failure.

Heartware International Inc was incorporated in Delaware on July 29, 2008 and became the successor issuer to HeartWare Limited, an Australian corporation, on November 13, 2008, as a result of the Australian Court approved redomiciliation of HeartWare Limited from Australia to Delaware. HeartWare is a medical device company engaged in developing implantable blood pumps for the treatment of advanced heart failure. The Company operates one reportable segment which includes the design, manufacture and marketing of medical devices for the treatment of advanced heart failure. The HeartWare Ventricular Assist System, which includes a left ventricular assist device, or blood pump, patient accessories and surgical tools, is designed to provide circulatory support for patients with advanced heart failure. Beyond the HeartWare System, the company is also evaluating its next device, the Miniaturized Ventricular Assist Device. The MVAD is based on the same technology platform as the HeartWare System but adopts an axial flow, rather than a centrifugal flow, configuration and is being developed in multiple configurations. The MVAD designs are currently at the preclinical stage and undergoing animal studies focused on minimally invasive implantation techniques and are each approximately one-third the size of the HVAD Pump. The Company's competitors in the implantable cardiac assist space include Thoratec Corporation, Jarvik Heart, Inc., MicroMed Cardiovascular, Berlin Heart GmbH, and Sunshine Heart, Inc. HEARTWARE, HVAD, MVAD, PAL, CIRCULITE, SYNERGY and various company logos are the trademarks of the Company, in the United States, Europe, Australia and other countries.

Ratios

vs
industry
vs
history
P/B 3.01
HTWR's P/B is ranked lower than
54% of the 302 Companies
in the Global Medical Devices industry.

( Industry Median: 2.92 vs. HTWR: 3.01 )
Ranked among companies with meaningful P/B only.
HTWR' s P/B Range Over the Past 10 Years
Min: 2.64  Med: 7.28 Max: 20.14
Current: 3.01
2.64
20.14
P/S 1.96
HTWR's P/S is ranked higher than
60% of the 293 Companies
in the Global Medical Devices industry.

( Industry Median: 3.07 vs. HTWR: 1.96 )
Ranked among companies with meaningful P/S only.
HTWR' s P/S Range Over the Past 10 Years
Min: 1.75  Med: 10.73 Max: 132.21
Current: 1.96
1.75
132.21
Current Ratio 5.44
HTWR's Current Ratio is ranked higher than
81% of the 317 Companies
in the Global Medical Devices industry.

( Industry Median: 2.86 vs. HTWR: 5.44 )
Ranked among companies with meaningful Current Ratio only.
HTWR' s Current Ratio Range Over the Past 10 Years
Min: 1.23  Med: 7.89 Max: 23.06
Current: 5.44
1.23
23.06
Quick Ratio 4.56
HTWR's Quick Ratio is ranked higher than
80% of the 317 Companies
in the Global Medical Devices industry.

( Industry Median: 2.07 vs. HTWR: 4.56 )
Ranked among companies with meaningful Quick Ratio only.
HTWR' s Quick Ratio Range Over the Past 10 Years
Min: 1.23  Med: 6.56 Max: 21.57
Current: 4.56
1.23
21.57
Days Inventory 168.91
HTWR's Days Inventory is ranked lower than
64% of the 284 Companies
in the Global Medical Devices industry.

( Industry Median: 136.99 vs. HTWR: 168.91 )
Ranked among companies with meaningful Days Inventory only.
HTWR' s Days Inventory Range Over the Past 10 Years
Min: 171.01  Med: 188.60 Max: 8207.82
Current: 168.91
171.01
8207.82
Days Sales Outstanding 41.07
HTWR's Days Sales Outstanding is ranked higher than
88% of the 273 Companies
in the Global Medical Devices industry.

( Industry Median: 68.64 vs. HTWR: 41.07 )
Ranked among companies with meaningful Days Sales Outstanding only.
HTWR' s Days Sales Outstanding Range Over the Past 10 Years
Min: 46.9  Med: 74.48 Max: 268.25
Current: 41.07
46.9
268.25
Days Payable 47.99
HTWR's Days Payable is ranked lower than
61% of the 266 Companies
in the Global Medical Devices industry.

( Industry Median: 61.70 vs. HTWR: 47.99 )
Ranked among companies with meaningful Days Payable only.
HTWR' s Days Payable Range Over the Past 10 Years
Min: 52.74  Med: 71.80 Max: 3270.96
Current: 47.99
52.74
3270.96

Valuation & Return

vs
industry
vs
history
Price/Net Current Asset Value 42.83
HTWR's Price/Net Current Asset Value is ranked lower than
92% of the 217 Companies
in the Global Medical Devices industry.

( Industry Median: 6.73 vs. HTWR: 42.83 )
Ranked among companies with meaningful Price/Net Current Asset Value only.
HTWR' s Price/Net Current Asset Value Range Over the Past 10 Years
Min: 5  Med: 14.29 Max: 44.89
Current: 42.83
5
44.89
Price/Tangible Book 5.81
HTWR's Price/Tangible Book is ranked lower than
68% of the 273 Companies
in the Global Medical Devices industry.

( Industry Median: 3.64 vs. HTWR: 5.81 )
Ranked among companies with meaningful Price/Tangible Book only.
HTWR' s Price/Tangible Book Range Over the Past 10 Years
Min: 4.82  Med: 8.48 Max: 20.93
Current: 5.81
4.82
20.93
Price/Median PS Value 0.18
HTWR's Price/Median PS Value is ranked higher than
95% of the 273 Companies
in the Global Medical Devices industry.

( Industry Median: 1.03 vs. HTWR: 0.18 )
Ranked among companies with meaningful Price/Median PS Value only.
HTWR' s Price/Median PS Value Range Over the Past 10 Years
Min: 0.19  Med: 1.00 Max: 11.21
Current: 0.18
0.19
11.21
Earnings Yield (Greenblatt) (%) -11.38
HTWR's Earnings Yield (Greenblatt) (%) is ranked lower than
73% of the 315 Companies
in the Global Medical Devices industry.

( Industry Median: 0.70 vs. HTWR: -11.38 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) (%) only.
HTWR' s Earnings Yield (Greenblatt) (%) Range Over the Past 10 Years
Min: -14.55  Med: 0.70 Max: 0.7
Current: -11.38
-14.55
0.7

More Statistics

Revenue (TTM) (Mil) $261.9
EPS (TTM) $ -4.37
Beta0.47
Short Percentage of Float11.63%
52-Week Range $25.02 - 94.15
Shares Outstanding (Mil)17.54

Analyst Estimate

Dec16 Dec17 Dec18
Revenue (Mil $) 228 249 288
EPS ($) -3.73 -3.14 -2.60
EPS w/o NRI ($) -3.73 -3.14 -2.60
EPS Growth Rate
(3Y to 5Y Estimate)
N/A
» More Articles for HTWR

Headlines

Articles On GuruFocus.com
Weekly Three-Year Low Highlights: Gap, NRG Energy, Buckle, HeartWare International Oct 13 2015 
Baron Funds Comments on HeartWare International May 05 2014 
Heartware International Inc (HTWR) CFO & COO David Mcintyre sells 2,857 Shares Feb 24 2011 
Heartware International Inc (HTWR) CFO & COO David Mcintyre sells 21,834 Shares Apr 30 2010 
Heartware International Inc (HTWR) CFO & COO David Mcintyre sells 5,271 Shares Mar 09 2010 
Heartware International Inc (HTWR) CFO & COO David Mcintyre sells 3,300 Shares Feb 26 2010 
Heartware International Inc (HTWR) CFO & COO David Mcintyre sells 4,967 Shares Jan 29 2010 
Heartware International Inc (HTWR) CFO & COO David Mcintyre sells 2,521 Shares Dec 07 2009 
Heartware International Inc (HTWR) CFO & COO David Mcintyre sells 1,580 Shares Dec 03 2009 
Heartware International Inc (HTWR) CFO & COO David Mcintyre sells 3,400 Shares Nov 30 2009 

More From Other Websites
HeartWare International, Inc. – Value Analysis (NASDAQ:HTWR) : June 9, 2016 Jun 09 2016
Coverage initiated on HeartWare by Guggenheim Jun 09 2016
HeartWare International, Inc. breached its 50 day moving average in a Bullish Manner : HTWR-US :... Jun 08 2016
HEARTWARE INTERNATIONAL, INC. Files SEC form 8-K, Submission of Matters to a Vote of Security... Jun 06 2016
HeartWare Presentation At The Goldman Sachs 37th Annual Global Healthcare Conference To Be Webcast Jun 01 2016
HeartWare Presentation At The Goldman Sachs 37th Annual Global Healthcare Conference To Be Webcast Jun 01 2016
ETF’s with exposure to HeartWare International, Inc. : May 19, 2016 May 19 2016
HEARTWARE INTERNATIONAL, INC. Financials May 13 2016
HeartWare International, Inc. :HTWR-US: Earnings Analysis: Q1, 2016 By the Numbers May 06 2016
HEARTWARE INTERNATIONAL, INC. Files SEC form 10-Q, Quarterly Report May 05 2016
HeartWare Presentation At The Bank Of America Merrill Lynch 2016 Health Care Conference To Be... May 05 2016
HeartWare International, Inc. breached its 50 day moving average in a Bearish Manner : HTWR-US : May... May 05 2016
Edited Transcript of HTWR earnings conference call or presentation 4-May-16 12:00pm GMT May 04 2016
HeartWare International Inc Earnings Call scheduled for 8:00 am ET today May 04 2016
HeartWare reports 1Q loss May 04 2016
HeartWare reports 1Q loss May 04 2016
HeartWare International Reports First Quarter 2016 Financial Results May 04 2016
HEARTWARE INTERNATIONAL, INC. Files SEC form 8-K, Results of Operations and Financial Condition,... May 04 2016
Q1 2016 HeartWare International Inc Earnings Release - Before Market Open May 04 2016

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)